Dr. Lewis Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded a grant from the Gray Foundation to study the genetic mutations that can lead to breast and ovarian cancer, investigating how early-stage precancerous cells can be recognized by the immune system and targeted with preventive or therapeutic cancer vaccines.
Simpson Thacher is representing the Gray Foundation in connection with the foundation’s donation of $25 million in funding for seven multi-institutional research teams to study new approaches for the early detection, diagnosis and therapy of BRCA-related cancers.
Jonathan and Mindy Gray have given $25 million through their foundation for research on genetic mutations that can lead to breast and ovarian cancer. The money will be shared by seven multidisciplinary research teams at the Cleveland Clinic, Harvard Medical School, Johns Hopkins University School of Medicine, the University of Pennsylvania, the University of Texas Health Science Center at San Antonio, Weill Cornell Medicine, and NewYork-Presbyterian/Weill Cornell Medical Center.
The Gray Foundation has awarded $25 million in funding to seven multi-institute teams conducting research related to the prediction, prevention, and treatment of BRCA-related cancers.
Katherine L. Nathanson, MD, deputy director of the Abramson Cancer Center at the University of Pennsylvania and the Pearl Basser Professor for BRCA-Related Research in Penn’s Perelman School of Medicine, has been awarded a $3 million research grant from the Gray Foundation.
Dr. Charis Eng, chair of Cleveland Clinic Genomic Medicine Institute, has received a $1.6 million grant from the Gray Foundation.
UT Health San Antonio leads consortium examining loss of DNA repair. Patrick Sung, D.Phil., of UT Health San Antonio, is the principal investigator of a $3.75 million, four-year “team science” grant announced today [July 23] by the Gray Foundation of New York.
On Tuesday, private equity tycoon Jonathan Gray and his wife Mindy announced $25 million in funding for research on pernicious genetic mutations that can lead to breast and ovarian cancer. The grants will be split among seven research teams across the globe, and brings the couple’s lifetime philanthropic giving to over $175 million — including over $100 million in BRCA research.
The Gray Foundation today awarded $25M in funding for seven multi-institutional research teams to study new approaches for the early detection, diagnosis, and therapy of BRCA-related cancers. These grants raise the Foundation’s giving to BRCA causes to over $100 million.